Vice President, Clinical Development
SERVIER MONDE
Summary
Servier is seeking a highly experienced and visionary clinical development leader to join its global Oncology Clinical Development Leadership Team. Reporting to the Global Head of Oncology Clinical Development, the Vice President, Oncology, Clinical Development will play a pivotal leadership role during a period of significant organizational growth and transformation.
Job description
Role Summary
Servier is seeking a highly experienced and visionary clinical development leader to join its global Oncology Clinical Development Leadership Team. Reporting to the Global Head of Oncology Clinical Development, the Vice President, Oncology, Clinical Development will play a pivotal leadership role during a period of significant organizational growth and transformation.
The Vice President will provide enterprise-level leadership for a substantial portion of Servier's oncology portfolio within an evolving, integrated development model. Programs may transition responsibility at Proof of Clinical Concept (POCC) or be advanced seamlessly from first-in-human (FIH) through registration.
In addition to portfolio leadership, this role carries shared accountability for defining, directing, and continuously improving the scientific strategy, operating model, and performance of the global oncology development organization.
Key Responsibilities
Enterprise & Strategic Leadership
- Direct clinical development strategy for a significant portion of the oncology portfolio, with primary focus on adult solid tumors and strategic input across the broader oncology pipeline.
- Serve as a core member of the Oncology Clinical Development Leadership Team with joint responsibility for portfolio prioritization, business development advice, and development governance.
- Represent Oncology Clinical Development at senior global governance forums and act as a designated delegate for the Global Head in executive decision-making bodies, as appropriate.
- Provide enterprise-level leadership in areas such as operational excellence, portfolio-wide development standards, and continuous improvement of decision-making frameworks.
Clinical Development Excellence
- Provide executive oversight for end-to-end clinical development programs, from early clinical planning through late-stage development, registration, and lifecycle management.
- Ensure high scientific and ethical standards across all clinical activities, including protocol design, safety oversight, data interpretation, and regulatory submissions.
- Apply seasoned clinical judgment to complex program, portfolio, and risk-benefit decisions at key development inflection points.
Cross-Functional & Global Collaboration
- Lead effectively within a highly matrixed, global organization, partnering across research, translational medicine, regulatory, safety, operations, commercial, and alliance teams.
- Drive alignment and continuity across early and late development activities, supporting Servier's integrated oncology development model.
- Build strong partnerships with global key opinion leaders, academic investigators, and external collaborators to support strategic objectives.
Organizational Leadership & Capability Building
- Lead and develop senior clinical development leaders, physicians, and scientists, with accountability for building sustainable organizational capability and succession.
- Set expectations and standards for leadership behaviors, talent development, and scientific excellence across the global clinical organization.
- Contribute to broader enterprise initiatives focused on leadership development, organizational effectiveness, and culture.
Education & Required Experience
- M.D. or equivalent medical degree.
- Board Certification or Eligibility in Oncology (Medical Oncology preferred).
- 12+ years of progressive experience in oncology drug development with 5+ years in mid-large pharma, including substantial late-stage and registrational leadership.
- Demonstrated track record of enterprise-level leadership, sound clinical judgment, and effective decision-making across complex portfolios.
- Deep expertise in adult solid tumors; broader oncology experience, including hematologic malignancies, is desirable.
- Proven success operating in a global, highly matrixed environment with significant cross-functional influence.
- Experience representing clinical development at senior governance forums and engaging with health authorities is strongly preferred.
Travel & Location
Up to 20% travel (domestic and international). Boston-based hybrid role (2-3 days/week in the Boston Seaport office).
Requirements
- M.D. or equivalent medical degree
- Board Certification or Eligibility in Oncology (Medical Oncology preferred)
- 12+ years of progressive experience in oncology drug development
- 5+ years in mid-large pharma
- Substantial late-stage and registrational leadership experience
- Demonstrated track record of enterprise-level leadership
- Deep expertise in adult solid tumors
- Proven success operating in a global, highly matrixed environment
- Experience representing clinical development at senior governance forums and engaging with health authorities (preferred)
- Broader oncology experience including hematologic malignancies (desirable)
Benefits
- Medical, Dental & Vision
- Flexible time off
- 401(k)
- Life insurance
- Disability insurance
- Recognition programs
- Short-Term & Long-Term incentives
Company overview
Servier, officially known as Laboratoires Servier, is a leading international pharmaceutical company founded in 1954 and headquartered in Suresnes, France. As the second largest French pharmaceutical group and the leading independent French pharmaceutical company, Servier operates in close to 140 countries worldwide, with 82% of its sales generated outside France. The company specializes in three main therapeutic areas: oncology, cardiometabolism & venous diseases, and neurology, with a particular focus on becoming a significant player in oncology, especially for rare cancers. Servier is governed by a unique non-profit foundation model that preserves its independence and allows for long-term strategic vision. The company invests approximately 20% of its brand-name medicine revenue into research and development annually, employing over 22,000 people globally, including 3,000 dedicated to R&D. With revenue of €5.9 billion in 2023/2024, Servier maintains 13 production sites and 6 research centers worldwide, producing 95.8% of active ingredients for its brand-name medicines in France. The company has established itself as a world leader in cardiology and hypertension treatments while expanding its oncology portfolio through strategic acquisitions and partnerships.